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Short-term effects of smoking marijuana 
on balance in patients with Gultip1'e 
sclerosis and nbrmal volunteers 
A double-blind randomized placebo-controlled study of inhaled marijuana smoke on postural responses 
was performed in 10 adult patients with spastic multiple sclerosis (MS) and 10 normal volunteers 
matched as closely as possible for age, sex, and weight. A computer-controlled dynamic posturographic 
platform with a video line scan camera measured shoulder displacement in response to pseudorandom 
platform movements. Premarijuana smoking patient tracking was inferior to that of the normal volun- 
teers as indicated by the higher noise variance of the former. Smoking one marijuana cigarette contain- 
ing 1.54% A9-tetrahydrocannabinol increased postural tracking error in both the patients and normal 
control subjects with both eyes open and closed; this untoward effect was greatest for the patients. The 
tracking error was also accompanied by a decrease in response speed for the patients with their eyes 
closed. Marijuana smoking further impairs posture and balance in patients with spastic MS. (CLIN PHAR- 
MACOL THER 1994;55:324-8.) 
Harry S. Greenberg, MD, Susan A. S. Werness, PhD, James E. Pugh, MD, 
Robert 0. Andrus, PhD, David J. Anderson, PhD, and Edward F. Domino, MD 
Ann Arbor, Mich. 
Anecdotal reports frequently suggest that smoking 
marijuana has beneficial effects in spasticity. Consroe 
and snider' and Consroe and sandyk2 reviewed the 
scientific literature regarding the effects of marijuana 
and cannabinoids in various neurologic states, includ- 
ing spasticity; mostly beneficial results were reported 
(see their references 144 to 146 and 148 to 150). 
These clinical studies contrast with the dose-response 
study by Kipliner et al."n which marijuana smoking 
in a linear dose-response manner produced a deteriora- 
tion of mental, motor, and postural stance on a wob- 
ble board in normal volunteers. 
Postural regulation is a complex motor function that 
is dependent on the integration of several sensory mo- 
dalities and neuronal mechanisms at spinal, cerebral, 
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and cerebellar levels. Failure to maintain postural con- 
trol is an indication of a dysfunction in one or more of 
the subsystems involved. A decrease in postural con- 
trol is a sensitive index of undesirable motor effects of 
potential therapeutic antispastic agents, including use 
of marijuana by humans. 
The hypothesis of this study was that marijuana 
smoking would relieve the spasticity of patients with 
multiple sclerosis (MS) sufficiently to allow better 
postural control and thus produce a therapeutic bene- 
fit. Therefore neurologically normal subjects and pa- 
tients with MS matched for age, weight, and height 
were studied with use of a microcomputer-driven plat- 
form to measure postural stance. Pharmacokinetic or 
pharmacodynamic measures were not obtained be- 
cause the possible therapeutic benefit or side effects of 
single exposure to marijuana smoke was of special in- 
terest. 
METHODS 
Testing apparatus. The posture measurement sys- 
tem consisted of a stimulus delivery component, a re- 
sponse measurement component, and a microcom- 
puter with an appropriate amount of memory and 
necessary interfaces for data acquisition and analysis. 
The balance perturbation was delivered by way of a 
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Fig. 1. 
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Schematic diagram of platform with video line scan cameras focused on shoulders 
hips of patient. 
translating p l a t f ~ r m . ~  Fig. 1 illustrates the platform 
with a subject on board. The response measurement 
portion of the system was composed of two digital 
line scan cameras that sensed the average position of 
the sagittal plane body silhouette of the subject stand- 
ing on the moving platform in a configuration for in- 
duced anteroposterior sway. One camera scanned hor- 
izontally at the shoulder level while the other scanned 
at the waist. The line scan camera measurements of 
waist and shoulder position were resolvable to the 
nearest 0.175 cm. Mass storage of data was provided 
by floppy discs. The characteristics of the posture 
measurement system and its application have been de- 
scribed in detail elsewhere4-'; therefore only a brief 
description is provided here. 
Stimulus characteristics. Pseudorandom displace- 
ment stimuli were generated for each trial. Stimuli of 
7.5 c d s e c  peak velocity of motion were used. 
Measured variables. Twenty seconds of actively 
filtered measurements for the shoulder, waist, and 
platform positions were sampled and stored on floppy 
discs at a rate of 25 Hz per channel. In the models de- 
rived, the measured platform position was the deter- 
ministic input time series, whereas the measured 
and 
shoulder and waist positions comprised the output 
time series. In both the eyes-open and eyes-closed 
trials, the subjects' postural responses usually showed 
a transient period of a few seconds in which the re- 
sponse characteristics were significantly changing, fol- 
lowed by a less variable steady-state phase. Only the 
steady-state phase, the last 10 seconds (eyes closed) or 
the last 14 seconds (eyes open), was used in the data 
analysis before and immediately after marijuana 
smoking. 
Experimental protocol. This study was approved 
by the University of Michigan Medical Center Institu- 
tional Review Board for Research Involving Human 
Subjects. Before the first experimental session and af- 
ter explanation of the testing procedures, an informed 
consent was signed by each volunteer. Each subject 
was tested in a double-blind trial on 3 consecutive 
days. On 2 of those days, the subject received active 
marijuana on one day and placebo on the other. A sin- 
gle marijuana (1.54% a9-tetrahydrocannabinol [A9- 
THC]) or alcohol-extracted marijuana placebo ciga- 
rette was smoked and inhaled by each subject taking 
deep breaths over 10 minutes. Ten minutes after com- 
pletion of smoking, each subject control was tested on 
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Table I. Significant normal subject and patient posture model parameters in ANOVA analysis* 
Patients Normal subjects Signijicance level 
Factor Eyes open Eyes closed Eyes open Eyes closed Healthf Eyes# 
-- - - 
Dead time 8.12 7.96 6.05 6.29 0.0001 NS 
Signal variance 0.3890 5.060 0.0719 3.430 0.0054 0.0000 
Noise variance 0.9790 3.780 0.5800 2.040 0.007 0.0000 
1.4 Hz phase lag 4.11 4.15 4.33 3.53 0.0359 0.0274 
0.2 Hz gain 1.32 2.30 0.581 2.09 NS 0.0000 
SNR 0.4750 1.140 0.1470 1.590 NS 0.0000 
Residual 0.020 0.034 0.020 0.028 NS 0.0001 
- 
Not significant; 0.2 Hz gain, low frequency transfer function gain; SNR, signal to noise ratio 
*Numbers in this table are group means, except where indicated. 
+Health, Patients versus normal subjects for factor in ANOVA analysis. 
$Eyes, Eyes-open versus eyes-closed for factor in ANOVA analysis 
$Median. 
the platform at about the time a peak plasma concen- 
tration of A9-THC is expected after inha~at ion.~  Rest 
periods were provided at the beginning of a session 
and every 20 minutes throughout. The subject was in- 
structed to stand in his or her stocking feet, at a 45- 
degree angle, heels together, head upright, arms com- 
fortably folded across the chest, and knees locked. Ear 
protectors were worn to minimize the effects of any 
background noise. The subject's eyes were either open 
and fixed on a target at eye level or closed, depending 
on the requirements of the specific trials. Each session 
consisted of twenty 20-second trials. These trials, ran- 
domly mixed by a computer program, were either 
static (no platform motion), transient, or pseudoran- 
dom in nature. Shoulder responses (before treatment 
and after treatment) in the eyes-open and eyes-closed 
paradigm from the placebo and the second of the 2 
drug days were analyzed, yielding a total of 160 pos- 
tural response measures. Only pseudorandom move- 
ment in patients and control subjects in the eyes-open 
and eyes-closed paradigms were analyzed focusing on 
the shoulder response. 
Patients. All 10 patients had MS by clinical and 
laboratory criteria with the predominant clinical deficit 
a spastic myelopathy (Table I). There were five male 
and five female patients with a median age of 32 years 
(range, 21 to 55 years). All patients had a stiff-legged 
gait with circumduction of at least one leg. Four pa- 
tients were subjectively classified as having mild and 
six moderate gait dysfunction. Eight patients had in- 
creased lower extremity tone or reflexes or both. 
Seven patients had bilaterally present Babinski re- 
sponses and one patient had unilaterally present Bab- 
inski responses. Six patients had a decrease in lower 
extremity sensory modalities and two had a sensory 
pin level in the thoracic area. All 10 patients had mild 
definite secondary areas of involvement of their ner- 
vous system other than the spinal cord, two with optic 
nerve involvement, two with brain stem dysfunction, 
and nine with cerebellar or brain stem dysfunction. 
Ten normal subjects without cardiac, rheumatologic, 
or neurologic disease were matched for sex, age, 
weight, and height to the 10 patients with multiple 
sclerosis with no age variance of greater than 3 years, 
weight variance greater than 10 pounds, or height 
variance greater than 2 inches. 
Mathematical analysis. A linear time invariant dif- 
ference equation model was postulated to be appropri- 
ate for the steady-state portion of the pseudorandom 
responses. The mathematic model and computer pro- 
gram have been described in detail e l ~ e w h e r e . ' ~ ~  
Statistical analyses. The postural response model 
data were subjected to an ANOVA analysis to deter- 
mine statistically significant effects attributable to the 
treatment, MSInormal subject factor, the presence or 
absence of vision, or the sex of the subject. 
RESULTS 
The patients and control subjects did not differ sig- 
nificantly in age, weight, or height. Dynamic postur- 
ography revealed statistically significantly different 
baseline presmoking measures in the patients with MS 
and the normal control subjects (Table I). In addition, 
statistically significant different responses to smoking 
a single marijuana cigarette were obtained in the pa- 
tients with MS and the normal control subjects (Table 
11). It was observed in patients with MS at baseline 
that the severity of the myelopathy seemed to correlate 
with the degree of posturographic abnormality. Table 
I lists in order of significance those features of the 
parametric models in which the normal subjects dif- 
fered significantly from the patients with MS. 
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Table 11. Significant marijuana treatment parameters from ANOVA analysis* 
Patients Normal subjects 
Presmoking Placebo Marijuana Presmoking Placebo Marijuana 
EO EC EO EC EO EC EO EC EO EC EO EC 
Noise variance 1.02 4.83 0.72 3.27 1.671 5.731 0.59 1.93 0.59 3.20 0.791 2.80t 
Totalphaselag 4.06 3.77 3.74 3.41 4.19 5.551 4.18 3.67 5.04 3.27 4.2 3.41 
EO, Eyes open; EC, eyes closed. 
*Numbers in table are group means. 
tTreatment factor (marijuana smoking) significant at p = 0.0025 for comparison of premarijuana versus postmanjuana. 
Transfer function and noise modalities. In normal 
subjects (Table I, columns 3 and 4), the damping ef- 
fect of vision on postural responses was seen in the 
smaller 0.2 Hz gains and smaller variances (signal, 
noise, and residual) for the eyes-open responses. Vi- 
sion had a reduced damping effect on the patient pos- 
tural responses (Table I, columns 1 and 2). The signal 
variance, noise variance, and dead time were all much 
larger for patients than for normal subjects with both 
eyes open and eyes closed (Table I, Health). 
Effects of marijuana smoking. All of the subjects 
(patients with MS and normal control subjects) ob- 
tained a more obvious psychologic "high" from the 
active than extracted marijuana cigarette. In both the 
patients with MS and age-matched control subjects, 
there were no gross changes in the neurologic exami- 
nation after active marijuana smoke inhalation or ex- 
tracted marijuana smoke inhalation. Two features of 
the parametric models were strongly affected by the 
presence of active marijuana smoke (Table 11). In both 
the eyes-open and eyes-closed paradigms, for both 
normal subjects and patients, noise variance values, 
when compared with their respective presmoking con- 
trol states, increased with active marijuana smoke in- 
halation. This effect was greatest for the patients. For 
the eyes-closed paradigm, smoking active marijuana 
increased the phase lags with which patients tracked 
the platform. A corresponding increase in phase lag 
from baseline was not observed for the normal sub- 
jects. 
DISCUSSION 
Dynamic posturography is a technique that has been 
shown to be sensitive to alterations in postural control 
mechanisms in patients with MS. Parker and ~ e r i c h "  
reported dynamic posturography monitoring of bal- 
ance before and during intravenous corticotropin and 
methylprednisolone treatment. The authors thought 
that dynamic posturography was a quantifiable objec- 
tive technique that documented the worsening and im- 
provement in neurologic functioning that occurred 
with treatment. lo  
Surprisingly, neither extracted marijuana nor active 
marijuana smoke inhalation had a discernible effect in 
patients or control subjects on standard clinical neuro- 
logic examination of motor, sensory, cerebellar, or re- 
flex testing. Patients often had the subjective feeling 
that they were clinically improved, yet postural re- 
sponses of both normal subjects and patients were ad- 
versely affected in terms of noise variance; the nega- 
tive effect was greatest in the patients. This 
observation provides evidence that single exposures to 
marijuana smoke interfere sufficiently with sensory- 
motor signal processing to cause even the normal sub- 
jects with visual stabilization to revert to a safer pos- 
tural strategy than the energy minimizing one. 
Smoking marijuana increased the response delay in 
patients with eyes closed but not in the normal sub- 
jects. This may be caused by interference with sensory 
processing when visual cues are removed. 
Petro and ~ l l e n b e r ~ e r "  reported on the effects of 
A9-THC on spasticity in nine patients. Four patients 
responded to A 9 - ~ ~ c  with significant improvement of 
a spasticity score composed of reflexes, tone, and 
Babinski signs. In four patients the visual electromyo- 
graphic interference pattern was reduced after a9- 
THC. Three patients reported feeling better, but only 
two had objective improvement. cliffordI2 reported 
two severely disabled patients with MS with ataxia 
and tremor whose tremor but not ataxia was objec- 
tively improved. Five of six other patients had subjec- 
tive, but no objective, improvement. 
Smoking marijuana is a rapid and convenient 
method of administering h9-THC, its active ingredi- 
ent. However, smoking suffers from variability in in- 
haling and, hence, variability in dosage. Dose-effect 
relationships are obscured. However, it is pertinent to 
determine if smoking just one marijuana cigarette in 
amounts sufficient to produce a state of mild intoxica- 
tion has any effect on postural control. 
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Dynamic posturography is a precise, quantitative 
functional assessment of the body's response to per- 
turbational movements that are encountered as a nor- 
mal part of living. It is not a measure of spasticity. 
Dynamic posturography requires integration of indi- 
vidual components of the motor, sensory, vestibular, 
visual cerebral, and cerebellar systems. It is a more 
functional assessment of the body's response to pertu- 
bational movements that are encountered as a normal 
part of life than isolated gait, motor, sensory, reflex, 
or coordination testing. Marijuana smoking worsened 
the dynamic posturography of both the patients and 
the control subjects. Therefore the hypothesis that ini- 
tiated this research was not confirmed. The subclinical 
posturographic changes observed in ambulatory pa- 
tients with MS under the influence of marijuana lessen 
their ability to react to their environment. Obviously, 
marijuana should not be used in a spastic ambulant 
population because the spasticity reducing effect of 
marijuana or its active ingredient A 9 - ~ ~ c  reported by 
others is not translated into an improvement in re- 
sponding to changes in postural control. 
An intriguing question to be answered in future re- 
search is whether chronic daily marijuana smoking for 
weeks would lead to differential tolerance develop- 
ment, with tolerance to the body balance deficit while 
an improvement in spasticity was maintained. 
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